Visiogen, Inc. Garners $40,000,000 New Funding Round

  • Feed Type
  • Date
    4/27/2009
  • Company Name
    Visiogen, Inc.
  • Mailing Address
    2 Goodyear Irvine, CA 92618
  • Company Description
    Visiogen, Inc. is focused on developing innovative products for cataract and refractive patients. Founded in Irvine, California, in 2001, Visiogen’s first commercial application, Synchrony®, a dual-optic intraocular lens and pre-loaded injector, is currently in clinical studies in the U.S. and recently received a CE Mark in Europe.
  • Website
    http://www.visiogen.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $40,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    “The funds we have raised will give us the flexibility and resources necessary to maximize the commercial impact of the Synchrony IOL,” said Reza Zadno, CEO and Founder of Visiogen, Inc.
  • M&A Terms
  • Venture Investor
    Novartis
  • Venture Investor
    Three Arch Partners
  • Venture Investor
    Technology Partners
  • Venture Investor
    New Leaf Venture Partners
  • Venture Investor
    Prospect Venture Partners
  • Venture Investor
    CMEA Ventures
  • Venture Investor
    Foundation Medical Partners

By posting a comment, you agree to our terms and conditions.